|
Pelot, M R; Pearson, D A; Swenson, K et al. (1999) Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen. Biol Blood Marrow Transplant 5:133-43
|
|
Yang, Y G; Sykes, M (1999) The role of interleukin-12 in preserving the graft-versus-leukemia effect of allogeneic CD8 T cells independently of GVHD. Leuk Lymphoma 33:409-20
|
|
Dey, B; Yang, Y G; Preffer, F et al. (1999) The fate of donor T-cell receptor transgenic T cells with known host antigen specificity in a graft-versus-host disease model. Transplantation 68:141-9
|
|
Sykes, M; Pearson, D A; Taylor, P A et al. (1999) Dose and timing of interleukin (IL)-12 and timing and type of total-body irradiation: effects on graft-vs.-host disease inhibition and toxicity of exogenous IL-12 in murine bone marrow transplant recipients. Biol Blood Marrow Transplant 5:277-84
|
|
Dey, B R; Yang, Y G; Szot, G L et al. (1998) Interleukin-12 inhibits graft-versus-host disease through an Fas-mediated mechanism associated with alterations in donor T-cell activation and expansion. Blood 91:3315-22
|
|
Sykes, M (1996) Immunobiology of transplantation. FASEB J 10:721-30
|
